Siderophores as “Trojan Horses”: tackling multidrug resistance?

Siderophore Receptor-Mediated Uptake of Lactivicin Analogues in Gram-Negative Bacteria

(2014) Jeremy Starr et al.   JOURNAL OF MEDICINAL CHEMISTRY

Siderophore-dependent iron uptake systems as gates for antibiotic Trojan horse strategies against Pseudomonas aeruginosa

(2014) Gaëtan L. A. Mislin et al.   Metallomics

Siderophore conjugates

(2013) Malcolm G. P. Page   Annals of the New York Academy of Sciences

Trihydroxamate Siderophore–Fluoroquinolone Conjugates Are Selective Sideromycin Antibiotics that Target Staphylococcus aureus

(2013) Timothy A. Wencewicz et al.   BIOCONJUGATE CHEMISTRY

Antibiotics in the clinical pipeline in 2013

(2013) Mark S Butler et al.   JOURNAL OF ANTIBIOTICS

Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilli

(2013) B. Hofer et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Biscatecholate–Monohydroxamate Mixed Ligand Siderophore–Carbacephalosporin Conjugates are Selective Sideromycin Antibiotics that Target Acinetobacter baumannii

(2013) Timothy A. Wencewicz et al.   JOURNAL OF MEDICINAL CHEMISTRY

Gram-positive siderophore-shuttle with iron-exchange from Fe-siderophore to apo-siderophore byBacillus cereusYxeB

(2013) Tatsuya Fukushima et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mammalian iron metabolism and its control by iron regulatory proteins

(2012) Cole P. Anderson et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii

(2012) P. G. Higgins et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Syntheses of mycobactin analogs as potent and selective inhibitors of Mycobacterium tuberculosis

(2012) Raúl E. Juárez-Hernández et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

In vitro activity of BAL30072 against Burkholderia pseudomallei

(2011) Takehiko Mima et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii

(2011) T. A. Russo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Design, Synthesis, and Study of a Mycobactin−Artemisinin Conjugate That Has Selective and Potent Activity against Tuberculosis and Malaria

(2011) Marvin J. Miller et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

In Vitro Properties of BAL30072, a Novel Siderophore Sulfactam with Activity against Multiresistant Gram-Negative Bacilli

(2010) M. G. P. Page et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Battle for Iron between Bacterial Pathogens and Their Vertebrate Hosts

(2010) Eric P. Skaar   PLoS Pathogens

Siderocalins: siderophore-binding proteins of the innate immune system

(2009) Matthew C. Clifton et al.   BIOMETALS

Siderophores as drug delivery agents: application of the “Trojan Horse” strategy

(2009) Ute Möllmann et al.   BIOMETALS

Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters

(2009) S. Mushtaq et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY